VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
Canada - TSX:VHI - CA92847V5018 - Common Stock
10.88 CAD
+0.32 (+3.03%)
We assign a fundamental rating of 6 out of 10 to VHI. VHI was compared to 9 industry peers in the Health Care Technology industry. VHI gets an excellent profitability rating and is at the same time showing great financial health properties. VHI is growing strongly while it is still valued neutral. This is a good combination! This makes VHI very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year VHI was profitable.
In the past year VHI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: VHI reported negative net income in multiple years.
VHI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
VHI has a better Return On Assets (1.79%) than 100.00% of its industry peers.
VHI has a better Return On Equity (2.71%) than 100.00% of its industry peers.
With an excellent Return On Invested Capital value of 3.20%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for VHI is in line with the industry average of 3.20%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.79% | ||
| ROE | 2.71% | ||
| ROIC | 3.2% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 5.99%, VHI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
VHI has a better Operating Margin (12.27%) than 100.00% of its industry peers.
In the last couple of years the Operating Margin of VHI has grown nicely.
The Gross Margin of VHI (80.89%) is better than 88.89% of its industry peers.
In the last couple of years the Gross Margin of VHI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.27% | ||
| PM (TTM) | 5.99% | ||
| GM | 80.89% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VHI is destroying value.
Compared to 1 year ago, VHI has more shares outstanding
VHI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for VHI has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.99 indicates that VHI is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.99, VHI is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
VHI has a debt to FCF ratio of 1.16. This is a very positive value and a sign of high solvency as it would only need 1.16 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.16, VHI belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
VHI has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
VHI's Debt to Equity ratio of 0.08 is fine compared to the rest of the industry. VHI outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.16 | ||
| Altman-Z | 4.99 |
ROIC/WACC0.35
WACC9.15%
2.3 Liquidity
A Current Ratio of 1.59 indicates that VHI should not have too much problems paying its short term obligations.
VHI has a Current ratio of 1.59. This is in the better half of the industry: VHI outperforms 77.78% of its industry peers.
VHI has a Quick Ratio of 1.59. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.59, VHI is doing good in the industry, outperforming 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.59 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 0.00% over the past year.
VHI shows a strong growth in Revenue. In the last year, the Revenue has grown by 41.68%.
VHI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 46.32% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
Revenue 1Y (TTM)41.68%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%46.93%
3.2 Future
The Earnings Per Share is expected to grow by 82.60% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 27.28% on average over the next years. This is a very strong growth
EPS Next Y67.73%
EPS Next 2Y111.49%
EPS Next 3Y82.6%
EPS Next 5YN/A
Revenue Next Year53.53%
Revenue Next 2Y36.13%
Revenue Next 3Y27.28%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 108.80, VHI can be considered very expensive at the moment.
100.00% of the companies in the same industry are more expensive than VHI, based on the Price/Earnings ratio.
VHI is valuated expensively when we compare the Price/Earnings ratio to 26.89, which is the current average of the S&P500 Index.
VHI is valuated quite expensively with a Price/Forward Earnings ratio of 34.75.
VHI's Price/Forward Earnings ratio is rather cheap when compared to the industry. VHI is cheaper than 88.89% of the companies in the same industry.
VHI's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.99.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 108.8 | ||
| Fwd PE | 34.75 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VHI indicates a rather cheap valuation: VHI is cheaper than 100.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of VHI indicates a rather cheap valuation: VHI is cheaper than 88.89% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 50.98 | ||
| EV/EBITDA | 33.86 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
VHI has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as VHI's earnings are expected to grow with 82.60% in the coming years.
PEG (NY)1.61
PEG (5Y)N/A
EPS Next 2Y111.49%
EPS Next 3Y82.6%
5. Dividend
5.1 Amount
No dividends for VHI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VHI (10/24/2025, 7:00:00 PM)
10.88
+0.32 (+3.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners28.48%
Inst Owner ChangeN/A
Ins Owners11.46%
Ins Owner ChangeN/A
Market Cap685.44M
Revenue(TTM)82.63M
Net Income(TTM)4.95M
Analysts81.43
Price Target15.78 (45.04%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-41.3%
Min EPS beat(2)-54.3%
Max EPS beat(2)-28.31%
EPS beat(4)0
Avg EPS beat(4)-35.59%
Min EPS beat(4)-54.3%
Max EPS beat(4)-25.74%
EPS beat(8)1
Avg EPS beat(8)-29.95%
EPS beat(12)1
Avg EPS beat(12)-44.36%
EPS beat(16)2
Avg EPS beat(16)-71.47%
Revenue beat(2)2
Avg Revenue beat(2)3.92%
Min Revenue beat(2)0.61%
Max Revenue beat(2)7.24%
Revenue beat(4)3
Avg Revenue beat(4)2.93%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)7.24%
Revenue beat(8)6
Avg Revenue beat(8)3.43%
Revenue beat(12)9
Avg Revenue beat(12)2.84%
Revenue beat(16)12
Avg Revenue beat(16)3.4%
PT rev (1m)-0.34%
PT rev (3m)5.31%
EPS NQ rev (1m)25%
EPS NQ rev (3m)-10.01%
EPS NY rev (1m)0%
EPS NY rev (3m)-46.81%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)5.03%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)17.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 108.8 | ||
| Fwd PE | 34.75 | ||
| P/S | 8.3 | ||
| P/FCF | 50.98 | ||
| P/OCF | 48.18 | ||
| P/B | 3.76 | ||
| P/tB | 22.04 | ||
| EV/EBITDA | 33.86 |
EPS(TTM)0.1
EY0.92%
EPS(NY)0.31
Fwd EY2.88%
FCF(TTM)0.21
FCFY1.96%
OCF(TTM)0.23
OCFY2.08%
SpS1.31
BVpS2.89
TBVpS0.49
PEG (NY)1.61
PEG (5Y)N/A
Graham Number2.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.79% | ||
| ROE | 2.71% | ||
| ROCE | 5.04% | ||
| ROIC | 3.2% | ||
| ROICexc | 5.66% | ||
| ROICexgc | N/A | ||
| OM | 12.27% | ||
| PM (TTM) | 5.99% | ||
| GM | 80.89% | ||
| FCFM | 16.27% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.16 | ||
| Debt/EBITDA | 0.87 | ||
| Cap/Depr | 10.65% | ||
| Cap/Sales | 0.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.38% | ||
| Profit Quality | 271.64% | ||
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.59 | ||
| Altman-Z | 4.99 |
F-Score3
WACC9.15%
ROIC/WACC0.35
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
EPS Next Y67.73%
EPS Next 2Y111.49%
EPS Next 3Y82.6%
EPS Next 5YN/A
Revenue 1Y (TTM)41.68%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%46.93%
Revenue Next Year53.53%
Revenue Next 2Y36.13%
Revenue Next 3Y27.28%
Revenue Next 5YN/A
EBIT growth 1Y23.46%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year69.12%
EBIT Next 3Y40.69%
EBIT Next 5YN/A
FCF growth 1Y81.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.62%
OCF growth 3YN/A
OCF growth 5YN/A
VITALHUB CORP / VHI.CA FAQ
What is the fundamental rating for VHI stock?
ChartMill assigns a fundamental rating of 6 / 10 to VHI.CA.
Can you provide the valuation status for VITALHUB CORP?
ChartMill assigns a valuation rating of 6 / 10 to VITALHUB CORP (VHI.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for VITALHUB CORP?
VITALHUB CORP (VHI.CA) has a profitability rating of 7 / 10.
What are the PE and PB ratios of VITALHUB CORP (VHI.CA) stock?
The Price/Earnings (PE) ratio for VITALHUB CORP (VHI.CA) is 108.8 and the Price/Book (PB) ratio is 3.76.